Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies, Inc.
Microarrays to be used in toxicogenomics research
September 10th, 2003
Agilent Technologies, Inc., (A) and Paradigm Genetics, Inc., (PDGM) introduced a 60-mer oligonucleotide mouse microarray as part of a previously announced collaboration. The new Agilent Mouse Oligo Microarray Kit provides researchers the ability to conduct genome-wide profiling research to better understand adverse drug reactions, physiological effects of toxins and toxic substances, and to study genetic diseases such as cancer. The mouse oligo microarray can be used to assess over 20,000 well-characterized mouse genes and transcripts, including a special set of toxicology markers defined through collaboration with several public and private...
Source: Biotech Week (2003-09-10)
|